By harnessing the power of precise knowledge of diabetes genetics and by putting our clients first, we work relentlessly to align our care model with the “precise” picture of your health to empower you to live your best life.

GemVCare
Making Life with Diabetes Better

Redefining You 

banner_logo_02.png
DForesee count 1.gif

DForesee®

Kelvin Wong - family history of diabetes

Discover how DForesee® cleared Kelvin’s doubts about the possibility on inheriting diabetes from his dad, and helped him devise the best care plan forward in reducing risk of developing the disease.

DForesee® Joy

Grace Ma - getting pregnant at age 35

Learn how DForesee® Joy helps Grace pin down her precise risk of developing gestational diabetes before her pregnancy, inform her exactly what to expect and how best to plan.

DForesee Joy count 1.gif
banner_logo_01.png
DProtect count 1.gif

DProtect®

Mr. Cheung - 55-year-old diabetes patient

Read how DProtect® helps Mr. Cheung plan his health goals by predicting his risks of potential complications as well as the pharmacological responses under different treatments.

MD35 Panel

Mrs Lam & her son - young diabetes patient

Find out how MD35 cleared up Mr Lam’s boy’s misdiagnosis of Type 1 diabetes and identified the cause of his diabetes, setting him back on an optimized treatment path which completely changed his life.

MD35 count 1.gif
banner_logo_02.png
FH final 2 .gif

Familial Hypercholesterolemia (FH) test

Maggie Leung and Her Family - FH patients

Find out how the tests that Maggie and her family took as part of the Familial Hypercholesterolemia (FH) test helped them realise why they had high cholesterol, agreed on an effective treatment strategy, reduce the risk of early on-set heart diseases and improve their health. 

banner_logo_02.png

My Gem® App

Tobby Lee - Type 2 diabetes patient

Explore how My Gem® App helps Tobby manage her Type 2 diabetes intuitively by providing lots of practical, easy-to-digest info and tracking all the things she can or needs to do to stay on top.

MyGem App count 1.gif

This story is inspired by our users' experiences and feedbacks and is presented here as illustration.

Since each patient is unique, our services should not be seen in any way as guaranteeing outcomes.

iStock-674948480.jpg

What are the advantages of personalized care for diabetes?

Personalized diabetes care refers to customised, precision-based solutions. Depending on your health condition and diabetes cause, we will create a health plan specified to your personal needs. 

 

For those belonging to a high-risk group, you can undergo precision testing to get a head start in understanding your potential risk. If you are diagnosed diabetes, our tests can give more information of condition to pave way for more progressive, holistic treatments. Or you may wish to do further precise assessments to allow your medical practitioners to advise you on advancing diabetes management plans so as to prevent or limit bad outcomes that comes with diabetes.

No matter your health status, you will always be our focus in this journey. We're in this together. 

Our Scope of Service

News

banner_form.jpg

Contact Us

arrow&v
Your question is ...

Thanks for submitting!

 

General Disclaimer

 

Gemomic® Technology is a university-owned, patented technology* which utilizes genetic tests to identify subjects who may develop diabetes and suffer its resulting complications. GemVCare Limited (referred to herein as “GemVCare”) hereby expressly disclaims any and all liability as follows: Any and all data, information and result including without limitation in connection with the GemVCare services, whether medically based or otherwise, which is provided under the Gemomic® Technology or otherwise (the “Services”) shall be used for reference purpose only. The Gemomic® Technology is not intended in any shape or form to be used, construed, interpreted or applied as a substitute for professional medical care, medical advice, diagnosis, therapeutic or prophylactic which shall be provided by a doctor, physician or other qualified medical/health care professionals. The causes, treatments and consequences of diabetes and its complications are complex and multifactorial. The interactions between bio-genetic markers and other risk factors and treatments require professional interpretation for decision making.Users of the Gemomic® Technology (including without limitations to users and family members of users), who receive, believe, rely or make decisions regarding their health or medical care based on risk predictions provided by the Gemomic® Technology do so at their own risk. Users are reminded to seek professional medical care, health management or other types of advice provided by a doctor, medical practitioner, physician, qualified health care professionals or other professionals after receiving results or reports from the Gemomic® Technology and all rights arising thereof and in relation to the Services include without limitation intellectual property shall belong to GemVCare. Neither the author(s) of the published reports relating to the risk associations of genetic variants and biomarkers and other relevant reports nor GemVCare including without limitations to its shareholders, directors, employees and consultants (if any) are liable or incur any duty of care for any decisions and/or consequences arising from or in relation to the assessment and/or interpretation of the results from the Gemomic® Technology or otherwise. The provision of Services is governed by terms and conditions contained in a respective separate document which this General Disclaimer forms part of and the respective liability caps described therein shall apply with respect to GemVCare’s liability stipulated in this General Disclaimer. No part of any publication may be reproduced or transmitted in any form without the prior written permission of GemVCare. In the event of any dispute or discrepancy between the English version and the translation of other languages of this General Disclaimer, the English version shall prevail.

 

*Patented technology means patents and pending applications licensed from the Chinese University of Hong Kong relating to DForesee® ,DProtect® and Monogenic Diabetes Panel.